8-812.a:
Transfusion of plasma, plasma components and infusion of volume replacement fluids: Transfusion of plasma and other plasma components and genetically engineered plasma proteins: Plasma-derived factor X
- 8-812.a0 Up to 500 units
- 8-812.a1 500 up to 1,000 units
- 8-812.a2 1,000 up to 2,000 units
- 8-812.a3 2,000 up to 3,000 units
- 8-812.a4 3,000 up to 4,000 units
- 8-812.a5 4,000 up to 5,000 units
- 8-812.a6 5,000 up to 10,000 units
- 8-812.a7 10,000 up to 15,000 units
- 8-812.a8 15,000 up to 20,000 units
- 8-812.a9 20,000 up to 25,000 units
- 8-812.aa 25,000 up to 30,000 units
- 8-812.ab 30,000 up to 35,000 units
- 8-812.ac 35,000 up to 40,000 units
- 8-812.ad 40,000 up to 45,000 units
- 8-812.ae 45,000 up to 50,000 units
- 8-812.af 50,000 up to 60,000 units
- 8-812.ag 60,000 up to 70,000 units
- 8-812.ah 70,000 up to 80,000 units
- 8-812.aj 80,000 up to 90,000 units
- 8-812.ak 90,000 up to 100,000 units
- 8-812.am 100,000 or more units
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).